BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Clinical Trial ID NCT00828009

PubWeight™ 6.93‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00828009

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer. Nat Rev Clin Oncol 2013 2.64
2 Molecular pathways and therapeutic targets in lung cancer. Oncotarget 2014 1.16
3 Advances in immunotherapy for treatment of lung cancer. Cancer Biol Med 2015 0.95
4 Immunotherapy in lung cancer. Transl Lung Cancer Res 2014 0.82
5 Tecemotide: an antigen-specific cancer immunotherapy. Hum Vaccin Immunother 2014 0.81
6 What lies within: novel strategies in immunotherapy for non-small cell lung cancer. Oncologist 2013 0.81
Next 100